Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Radiomedicine Technology
Beijing, Beijing, China
- Ownership
- Private
- Development stage
- Other
01
Overview
New Radiomedicine Technology (NRT) is a clinical-stage biopharmaceutical company based in Beijing, China, specializing in the development of innovative radiopharmaceuticals for cancer diagnosis and treatment. The company focuses on the 'theranostic' approach, utilizing radionuclide-labeled ligands to target specific biomarkers such as Fibroblast Activation Protein (FAP) and Prostate-Specific Membrane Antigen (PSMA). Their lead programs include novel FAP-targeted imaging and therapeutic agents designed to address a wide range of solid tumors. NRT integrates research, development, and clinical translation to advance next-generation precision nuclear medicine.
- Therapeutic areas
- Oncology
- Modalities
- RadiopharmaceuticalSmall moleculePeptides
- Industry
- Biotech
02
Partnerships
Peking University Cancer HospitalChinese Academy of Medical Sciences
Beyond the preview
Go deeper on New Radiomedicine Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on New Radiomedicine Technology.